Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal
Selma Ugurel

Showing results (191-200 of 490) with videos related to

Pageof 49
Sort By:
Cancer Immunology, Immunotherapy : CII|January 13, 2021
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinomaValerie Glutsch, Hermann Kneitz, Anja Gesierich, et al.
Archives of Dermatology|May 20, 2009
A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapyCarl Gebhardt, Marco Averbeck, Uwe Paasch, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2021
Clinical determinants of long-term survival in metastatic uveal melanomaElias A T Koch, Anne Petzold, Anja Wessely, et al.
Melanoma Research|July 18, 2006
Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genesSandra Bloethner, Kari Hemminki, Ranjit K Thirumaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy responseSelma Ugurel, Roland Houben, David Schrama, et al.
Cancer Letters|April 6, 2016
MicroRNAs as novel targets and tools in cancer therapyMohammed L Abba, Nitin Patil, Jörg H Leupold, et al.
Thrombosis and Haemostasis|November 8, 2005
Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergyJochen Utikal, Wiebke K Peitsch, Dirk Booken, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 20, 2023
9. Virtuelles Netzwerktreffen der zertifizierten Hautkrebszentren 26./27.01.2023Frank Meiß, Thomas K Eigentler, Margit Huber, et al.
Frontiers in Immunology|June 27, 2018
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint InhibitorsRebekka Weber, Viktor Fleming, Xiaoying Hu, et al.
International Journal of Cancer|August 16, 2018
Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulationHuizi Wu, Lionel Larribère, Qian Sun, et al.
Pageof 49

Showing results (191-200 of 490) with videos related to

Sort By:
Pageof 49
Cancer Immunology, Immunotherapy : CII|January 13, 2021
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinomaValerie Glutsch, Hermann Kneitz, Anja Gesierich, et al.
Archives of Dermatology|May 20, 2009
A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapyCarl Gebhardt, Marco Averbeck, Uwe Paasch, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2021
Clinical determinants of long-term survival in metastatic uveal melanomaElias A T Koch, Anne Petzold, Anja Wessely, et al.
Melanoma Research|July 18, 2006
Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genesSandra Bloethner, Kari Hemminki, Ranjit K Thirumaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy responseSelma Ugurel, Roland Houben, David Schrama, et al.
Cancer Letters|April 6, 2016
MicroRNAs as novel targets and tools in cancer therapyMohammed L Abba, Nitin Patil, Jörg H Leupold, et al.
Thrombosis and Haemostasis|November 8, 2005
Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergyJochen Utikal, Wiebke K Peitsch, Dirk Booken, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 20, 2023
9. Virtuelles Netzwerktreffen der zertifizierten Hautkrebszentren 26./27.01.2023Frank Meiß, Thomas K Eigentler, Margit Huber, et al.
Frontiers in Immunology|June 27, 2018
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint InhibitorsRebekka Weber, Viktor Fleming, Xiaoying Hu, et al.
International Journal of Cancer|August 16, 2018
Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulationHuizi Wu, Lionel Larribère, Qian Sun, et al.
Pageof 49